RN7SK pseudogene 273 (RN7SKP273)

RN7SKP273 is a non-coding RNA pseudogene belonging to the family of 7SK pseudogenes, which are derived from the 7SK small nuclear RNA gene[3]. The canonical 7SK snRNA itself plays a critical regulatory role in transcriptional elongation by RNA polymerase II (Pol II) through sequestration of positive transcription elongation factor b (P-TEFb)[1][4]. However, RN7SKP273 does not encode functional 7SK snRNA, and there is currently no evidence of it functioning as a therapeutic target, biomarker, or disease controller. Key clarifications: - RN7SKP273 is a pseudogene, not an active receptor, enzyme, transporter, or transcription factor[3]. - It is not a recognized therapeutic target, nor does it have known biological, disease, or pharmacological associations. - There are no documented drugs, mechanisms of action, or safety concerns related to RN7SKP273. - The correct molecular classification is "Other: Pseudogene". - If there was an intention to refer to the canonical 7SK snRNA (not pseudogene), then names should be corrected to indicate "7SK small nuclear RNA" (not pseudogene). Note: This entry is likely incorrect as a drug target, being a pseudogene with no recorded functional, disease, or pharmacological associations[3]. The canonical, functional molecule of interest is "7SK small nuclear RNA"; its pseudogenes, including RN7SKP273, do not have biological roles in humans and are not considered targets.

Other names

RN7SKP273RNA, 7SK small nuclear pseudogene 273